ProShare Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$54.5K Buy
2018
Q4
Sell
2018
Q3
$117K Sell
2018
Q2
$155K Buy
2018
Q1
$125K Sell
2017
Q4
$130K Buy